Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px

Product › Details

CTX110 allogeneic CAR T-cell therapy

	Next higher product group	CAR T-cell therapy product
	Status	2018-11-07 development pp existent
	Organisation	CRISPR Therapeutics AG (Nasdaq: CRSP)
	Group	CRISPR Therapeutics (Group)
	Source	CRISPR Therapeutics AG. (10/28/19). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results". Zug & Cambridge, MA.

Record changed: 2023-10-07

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for CAR T-cell therapy product

[1] Capstan Therapeutics, Inc.. (3/20/24). "Press Release: Capstan Therapeutics Announces $175M Oversubscribed Series B Financing". San Diego, CA....
[2] BioNTech SE. (2/8/24). "Press Release: BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs". Mainz & London....
[3] Gracell Biotechnologies Inc.. (12/26/23). "Press Release: Gracell Biotechnologies to Be Acquired by AstraZeneca, furthering Cell Therapy Ambition across Oncology and Autoimmune Diseases". San Diego, CA, Suzhou & Shanghai....
[4] AstraZeneca plc. (12/26/23). "Press Release: AstraZeneca to Acquire Gracell, Furthering Cell Therapy Ambition across Oncology and Autoimmune Diseases"....
[5] Legend Biotech Corporation. (11/13/23). "Press Release: Legend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3". Somerset, NJ....
[6] Max-Delbrück-Centrum für Molekulare Medizin (MDC). (9/21/23). "Press Release: Starting Up with Highly Promising Immunotherapies"....
[7] Invios GmbH. (9/5/23). "Press Release: Invios Starts Further Clinical Trial of APN401, Novel Cell Therapy Against Solid Cancers, and Secures Major Austrian Grant Funding". Vienna....
[8] T-Curx GmbH. (8/28/23). "Press Release: T-Curx GmbH Announces Appointment of Two Industry Leaders to Its Board of Directors"....
[9] Max-Delbrück-Centrum für Molekulare Medizin (MDC). (5/26/23). "Press Release: €4.6 Million for a Novel CAR T-cell Therapy". Berlin....
[10] CRISPR Therapeutics AG. (2/21/23). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results". Zug & Boston, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]